Journal article icon

Journal article

A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam

Abstract:
Background: COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to treat COVID-19. This clinical trial is designed to evaluate chloroquine as a potential therapeutic for the treatment of hospitalised people with COVID-19. We hypothesise that chloroquine slows viral replication in patients with COVID-19, attenuating the infection, and ... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author
ORCID:
0000-0002-5728-0918
Publisher:
F1000Research
Journal:
Wellcome Open Research More from this journal
Volume:
5
Article number:
141
Publication date:
2020-06-12
Acceptance date:
2020-10-19
DOI:
EISSN:
2398-502X
ISSN:
2398-502X
Pmid:
33110944
Language:
English
Keywords:
Pubs id:
1141100
Local pid:
pubs:1141100
Deposit date:
2021-01-20

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP